OGI vs. TELO, ALIM, IVA, SCPH, GLSI, ACRV, CAPR, LFCR, TRVI, and MCRB Should you be buying Organigram stock or one of its competitors? The main competitors of Organigram include Telomir Pharmaceuticals (TELO), Alimera Sciences (ALIM), Inventiva (IVA), scPharmaceuticals (SCPH), Greenwich LifeSciences (GLSI), Acrivon Therapeutics (ACRV), Capricor Therapeutics (CAPR), Lifecore Biomedical (LFCR), Trevi Therapeutics (TRVI), and Seres Therapeutics (MCRB). These companies are all part of the "pharmaceutical preparations" industry.
Organigram (NASDAQ:OGI ) and Telomir Pharmaceuticals (NASDAQ:TELO ) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, media sentiment, institutional ownership, risk, valuation, dividends, community ranking and profitability.
Organigram received 197 more outperform votes than Telomir Pharmaceuticals when rated by MarketBeat users.
34.6% of Organigram shares are held by institutional investors. 0.1% of Organigram shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
Telomir Pharmaceuticals has a net margin of 0.00% compared to Organigram's net margin of -188.38%. Telomir Pharmaceuticals' return on equity of 0.00% beat Organigram's return on equity.
Telomir Pharmaceuticals has lower revenue, but higher earnings than Organigram.
In the previous week, Organigram had 12 more articles in the media than Telomir Pharmaceuticals. MarketBeat recorded 15 mentions for Organigram and 3 mentions for Telomir Pharmaceuticals. Telomir Pharmaceuticals' average media sentiment score of 0.82 beat Organigram's score of 0.37 indicating that Telomir Pharmaceuticals is being referred to more favorably in the news media.
Summary Organigram beats Telomir Pharmaceuticals on 6 of the 11 factors compared between the two stocks.
This chart shows the number of new MarketBeat users adding OGI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Organigram Competitors List
Related Companies and Tools
